Significance of Exhaled Breath Test in Clinical Diagnosis: A Special Focus on the Detection of Diabetes Mellitus

Analysis of volatile organic compounds (VOCs) emanating from human exhaled breath can provide deep insight into the status of various biochemical processes in the human body. VOCs can serve as potential biomarkers of physiological and pathophysiological conditions related to several diseases. Breath VOC analysis, a noninvasive and quick biomonitoring approach, also has potential for the early detection and progress monitoring of several diseases. This paper gives an overview of the major VOCs present in human exhaled breath, possible biochemical pathways of breath VOC generation, diagnostic importance of their analysis, and analytical techniques used in the breath test. Breath analysis relating to diabetes mellitus and its characteristic breath biomarkers is focused on. Finally, some challenges and limitations of the breath test are discussed.

[1]  B. de Lacy Costello,et al.  A review of the volatiles from the healthy human body , 2014, Journal of breath research.

[2]  Edgard Delvin,et al.  Continuous glucose monitoring: a review of biochemical perspectives and clinical use in type 1 diabetes. , 2009, Clinical biochemistry.

[3]  David Zhang,et al.  A Novel Breath Analysis System Based on Electronic Olfaction , 2010, IEEE Transactions on Biomedical Engineering.

[4]  M. Phillips,et al.  Increased breath biomarkers of oxidative stress in diabetes mellitus. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[5]  A. Amann,et al.  Detection of potential chronic kidney disease markers in breath using gas chromatography with mass-spectral detection coupled with thermal desorption method. , 2013, Journal of chromatography. A.

[6]  X. Zhang,et al.  Determination of acetone in human breath by gas chromatography-mass spectrometry and solid-phase microextraction with on-fiber derivatization. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[7]  J. Porter,et al.  Biochemistry of polyisoprenoid biosynthesis. , 1976, Annual review of biochemistry.

[8]  Steven B. Karch.  Drug Abuse Handbook , 2006 .

[9]  Philipp Lirk,et al.  Mass spectrometric profile of exhaled breath—field study by PTR-MS , 2005, Respiratory Physiology & Neurobiology.

[10]  Joshua T. Morgan,et al.  Characterization of Volatile Organic Compounds in Human Leukocyte Antigen Heterologous Expression Systems: a Cell's “Chemical Odor Fingerprint” , 2012, Chembiochem : a European journal of chemical biology.

[11]  A Abu-Hanna,et al.  Exhaled breath analysis with electronic nose technology for detection of acute liver failure in rats. , 2014, Biosensors & bioelectronics.

[12]  Simone Meinardi,et al.  Breath ethanol and acetone as indicators of serum glucose levels: an initial report. , 2005, Diabetes technology & therapeutics.

[13]  M. Alonso,et al.  Analytical challenges in breath analysis and its application to exposure monitoring , 2013 .

[14]  H. Hill,et al.  Atmospheric pressure matrix-assisted laser desorption/ionization with analysis by ion mobility time-of-flight mass spectrometry. , 2004, Rapid communications in mass spectrometry : RCM.

[15]  D. B. Milligan,et al.  Application of selected ion flow tube mass spectrometry to real-time atmospheric monitoring. , 2010, Rapid communications in mass spectrometry : RCM.

[16]  T. Hamasaki,et al.  The assessment of methyl mercaptan, an important clinical marker for the diagnosis of oral malodor. , 2004, Journal of dentistry.

[17]  P. Mazzone,et al.  Detection of lung cancer by sensor array analyses of exhaled breath. , 2005, American journal of respiratory and critical care medicine.

[18]  M. Phillips,et al.  Increased oxidative stress in younger as well as in older humans. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[19]  W. Cao,et al.  Breath analysis: potential for clinical diagnosis and exposure assessment. , 2006, Clinical chemistry.

[20]  G. Wells.  Acetone. , 2018, Journal of environmental health.

[21]  H. Fuchs,et al.  Diet-induced and mono-genetic obesity alter volatile organic compound signature in mice , 2016, Journal of breath research.

[22]  Niki Fens,et al.  Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. , 2009, American journal of respiratory and critical care medicine.

[23]  R. N. Harger,et al.  A RAPID CHEMICAL TEST FOR INTOXICATION EMPLOYING BREATH: A NEW REAGENT FOR ALCOHOL AND A PROCEDURE FOR ESTIMATING THE CONCENTRATION OF ALCOHOL IN THE BODY FROM THE RATIO OF ALCOHOL TO CARBON DIOXIDE IN THE BREATH , 1938 .

[24]  T. Greulich,et al.  Detection of obstructive sleep apnoea by an electronic nose , 2012, European Respiratory Journal.

[25]  Ashutosh Tiwari,et al.  A review of recent advances in nonenzymatic glucose sensors. , 2014, Materials science & engineering. C, Materials for biological applications.

[26]  S. Kreuer,et al.  Exhalation pattern changes during fasting and low dose glucose treatment in rats , 2015, Analytical and Bioanalytical Chemistry.

[27]  J. Flores-Hernández,et al.  Diabetes induces pulmonary artery endothelial dysfunction by NADPH oxidase induction. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[28]  Hui Xu,et al.  New graphene fiber coating for volatile organic compounds analysis. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[29]  L. Young,et al.  Toxicology: The Basic Science of Poisons , 1976 .

[30]  A Bryan,et al.  Diabetic ketoacidosis. , 2005, American family physician.

[31]  E. Blaak.  Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance. , 2005, Best practice & research. Clinical endocrinology & metabolism.

[32]  U. Tegtbur,et al.  Experimental setup and analytical methods for the non-invasive determination of volatile organic compounds, formaldehyde and NOx in exhaled human breath. , 2010, Analytica chimica acta.

[33]  Borja G Cosio,et al.  Use of the electronic nose for diagnosing respiratory diseases. , 2012, Archivos de bronconeumologia.

[34]  C. Mayhew,et al.  Real-time breath monitoring of propofol and its volatile metabolites during surgery using a novel mass spectrometric technique: a feasibility study. , 2003, British journal of anaesthesia.

[35]  Massimo Corradi,et al.  Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[36]  John S. Payne,et al.  Sensor array techniques for mimicking the mammalian olfactory system , 1996 .

[37]  Yoshihiro Saito,et al.  Determination of breath isoprene and acetone concentration with a needle-type extraction device in gas chromatography-mass spectrometry. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[38]  B. Cosío,et al.  Utilidad de la nariz electrónica para el diagnóstico de enfermedades de la vía respiratoria , 2012 .

[39]  Guangming Lu,et al.  Non-invasive blood glucose monitoring for diabetics by means of breath signal analysis , 2012 .

[40]  I. Horváth,et al.  Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose , 2015, Sleep and Breathing.

[41]  J. Deslypere,et al.  A new non-invasive technology to screen for dysglycaemia including diabetes. , 2010, Diabetes research and clinical practice.

[42]  Anton Amann,et al.  Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas , 2007 .

[43]  Conrad Bessant,et al.  Electronic-Nose Technology Using Sputum Samples in Diagnosis of Patients with Tuberculosis , 2010, Journal of Clinical Microbiology.

[44]  Giorgio Pennazza,et al.  Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. , 2010, Chest.

[45]  Ildikó Horváth,et al.  Exhaled biomarker pattern is altered in children with obstructive sleep apnoea syndrome. , 2013, International journal of pediatric otorhinolaryngology.

[46]  W. Pryor.  FREE RADICAL BIOLOGY: XENOBIOTICS, CANCER, AND AGING * , 1982, Annals of the New York Academy of Sciences.

[47]  McGrath Lawrence T.,et al.  Breath isoprene in patients with heart failure , 2001 .

[48]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[49]  J. Troppmair,et al.  Characterization of volatile metabolites taken up by or released from Streptococcus pneumoniae and Haemophilus influenzae by using GC-MS. , 2012, Microbiology.

[50]  W. Pollock,et al.  Bacteria produce the volatile hydrocarbon isoprene , 1995, Current Microbiology.

[51]  J. Schubert,et al.  Application of a new method for analysis of exhaled gas in critically ill patients , 1998, Intensive Care Medicine.

[52]  C. Forsblom,et al.  Increased levels of α-defensin (-1, -2 and -3) in type 1 diabetic patients with nephropathy , 2007 .

[53]  P. Barnes,et al.  Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[54]  Massimo Corradi,et al.  Lung cancer biomarkers in exhaled breath , 2011, Expert review of molecular diagnostics.

[55]  Ameen Abu-Hanna,et al.  Glucose prediction by analysis of exhaled metabolites – a systematic review , 2014, BMC Anesthesiology.

[56]  A. Mazzatenta,et al.  Pathologies currently identified by exhaled biomarkers , 2013, Respiratory Physiology & Neurobiology.

[57]  M. Timio,et al.  Onset, Time Course, and Persistence of Increased Haemodialysis-Induced Breath Isoprene Emission , 2001, Nephron.

[58]  K. Pickard,et al.  The regulation of transaminative flux of methionine in rat liver mitochondria. , 1994, Archives of biochemistry and biophysics.

[59]  L. T. McGrath,et al.  Breath isoprene in patients with heart failure. , 2001, European Journal of Heart Failure.

[60]  S. Cohen-Kaminsky,et al.  Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath. , 2013, Annales pharmaceutiques francaises.

[61]  Claire Turner,et al.  Potential of breath and skin analysis for monitoring blood glucose concentration in diabetes , 2011, Expert review of molecular diagnostics.

[62]  Yixiang Duan,et al.  Breath biomarkers in diagnosis of pulmonary diseases. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[63]  W. Guan,et al.  Responsiveness to methacholine, but not leukotriene D4, correlates with fractional exhaled nitric oxide in asthma , 2016, The clinical respiratory journal.

[64]  M. Phillips.  Method for the collection and assay of volatile organic compounds in breath. , 1997, Analytical biochemistry.

[65]  Mark Libardoni,et al.  Analysis of human breath samples with a multi-bed sorption trap and comprehensive two-dimensional gas chromatography (GCxGC). , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[66]  G. Teschl,et al.  Isoprene and acetone concentration profiles during exercise on an ergometer , 2009, Journal of breath research.

[67]  B. Ed,et al.  Biochemistry of Polyisoprenoid Biosynthesis , 1976 .

[68]  Bogusław Buszewski,et al.  Analysis of exhaled breath for disease detection. , 2014, Annual review of analytical chemistry.

[69]  Joachim D Pleil,et al.  Clinical breath analysis: discriminating between human endogenous compounds and exogenous (environmental) chemical confounders , 2013, Journal of breath research.

[70]  D. Kearney,et al.  Breath Ammonia Measurement in Helicobacter pylori Infection , 2002, Digestive Diseases and Sciences.

[71]  Alok Banga,et al.  Evaluation of plasma ammonia levels in patients with acute liver failure and chronic liver disease and its correlation with the severity of hepatic encephalopathy and clinical features of raised intracranial tension. , 2005, Clinical biochemistry.

[72]  M. McEwan,et al.  Major volatile compounds in head-space above olive oil analysed by selected ion flow tube mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.

[73]  H. Keen,et al.  1 The definition and classification of diabetes mellitus , 1982 .

[74]  J. Mead,et al.  Isoprene-the main hydrocarbon in human breath. , 1981, Biochemical and biophysical research communications.

[75]  Karin Greiner,et al.  Elective haemodialysis increases exhaled isoprene. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[76]  A. Tangerman,et al.  New methods for the release of volatile sulfur compounds from human serum: its determination by Tenax trapping and gas chromatography and its application in liver diseases. , 1985, The Journal of laboratory and clinical medicine.

[77]  L. Bianchi,et al.  Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study , 2005, Respiratory research.

[78]  L. T. McGrath,et al.  Breath isoprene during acute respiratory exacerbation in cystic fibrosis. , 2000, The European respiratory journal.

[79]  Johnny Ludvigsson,et al.  Exhaled Isoprene and Acetone in Newborn Infants and in Children with Diabetes Mellitus , 1998, Pediatric Research.

[80]  Yuh-Jiuan Lin,et al.  Application of the electronic nose for uremia diagnosis , 2001 .

[81]  Terence H Risby,et al.  Breath biomarkers for detection of human liver diseases: preliminary study , 2002, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[82]  Ping Wang,et al.  A study of an electronic nose for detection of lung cancer based on a virtual SAW gas sensors array and imaging recognition method , 2005 .

[83]  R. Cataneo,et al.  Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study , 1999, The Lancet.

[84]  S. Vinogradov,et al.  Neutrophil alpha-defensins cause lung injury by disrupting the capillary-epithelial barrier. , 2010, American journal of respiratory and critical care medicine.

[85]  S Lenzi,et al.  Monitoring breath during oral glucose tolerance tests , 2013, Journal of breath research.

[86]  A. Hansel,et al.  Endogenous production of methanol after the consumption of fruit. , 1997, Alcoholism, clinical and experimental research.

[87]  C Hoeschen,et al.  Effects of diet-matrix on volatile organic compounds in breath in diet-induced obese mice , 2014, Journal of breath research.

[88]  L. Freitag,et al.  METABOLITES IN HUMAN BREATH: ION MOBILITY SPECTROMETERS AS DIAGNOSTIC TOOLS FOR LUNG DISEASES , 2005 .

[89]  Sara Salehi,et al.  Highly sensitive carbon nanotubes–SnO2 nanocomposite sensor for acetone detection in diabetes mellitus breath , 2014 .

[90]  A. Ceccarini,et al.  Breath analysis: trends in techniques and clinical applications , 2005 .

[91]  Bogusław Buszewski,et al.  Determination of volatile organic compounds in human breath for Helicobacter pylori detection by SPME-GC/MS. , 2011, Biomedical chromatography : BMC.

[92]  Rossana Salerno-Kennedy,et al.  Potential applications of breath isoprene as a biomarker in modern medicine: a concise overview , 2005, Wiener klinische Wochenschrift.

[93]  J. Timbrell,et al.  Casarett and Doull's Toxicology: The Basic Science of Poisons , 1981 .

[94]  David Smith,et al.  Progress in SIFT-MS: breath analysis and other applications. , 2011, Mass spectrometry reviews.

[95]  G B Bulkley,et al.  Ethane: a marker of lipid peroxidation during cardiopulmonary bypass in humans. , 1999, Free radical biology & medicine.

[96]  Naresh Magan,et al.  Electronic nose analysis of bronchoalveolar lavage fluid , 2011, European journal of clinical investigation.

[97]  T. Risby,et al.  Clinical application of breath biomarkers of oxidative stress status. , 1999, Free radical biology & medicine.

[98]  A. Soro-Paavonen,et al.  AGE-RAGE signalling in endothelial dysfunction and atherosclerosis in diabetes , 2010 .

[99]  T. Mitsui,et al.  Inadequacy of theoretical basis of breath methylated alkane contour for assessing oxidative stress. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[100]  R. Doty,et al.  Biochemical profile or uremic breath. , 1977, The New England journal of medicine.

[101]  M. Ezzati,et al.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants , 2011, The Lancet.

[102]  T. Risby,et al.  Breath ethane: a specific indicator of free-radical-mediated lipid peroxidation following reperfusion of the ischemic liver. , 1992, Free radical biology & medicine.

[103]  David Zhang,et al.  Design of a Breath Analysis System for Diabetes Screening and Blood Glucose Level Prediction , 2014, IEEE Transactions on Biomedical Engineering.

[104]  Alan Gelperin,et al.  Volatile compounds characteristic of sinus-related bacteria and infected sinus mucus: analysis by solid-phase microextraction and gas chromatography-mass spectrometry. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[105]  S. Telser,et al.  Applications of breath gas analysis in medicine , 2004 .

[106]  S. Pratsinis,et al.  Correlations between blood glucose and breath components from portable gas sensors and PTR-TOF-MS , 2013, Journal of breath research.

[107]  Dall Jl,et al.  MORE ACID/BASE DISTURBANCES. , 1963 .

[108]  Alex van Belkum,et al.  Diagnosis of active tuberculosis by e-nose analysis of exhaled air. , 2013, Tuberculosis.

[109]  T. Risby,et al.  Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. , 2000, Gastroenterology.

[110]  Arthur S Slutsky,et al.  Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases. , 2008, American journal of physiology. Heart and circulatory physiology.

[111]  A. Tappel,et al.  Hydrocarbon gases produced during in vitro peroxidation of polyunsaturated fatty acids and decomposition of preformed hydroperoxides , 1977, Lipids.

[112]  Julian King,et al.  A mathematical model for breath gas analysis of volatile organic compounds with special emphasis on acetone , 2010, Journal of mathematical biology.

[113]  P. Shah,et al.  Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction. , 2000, American journal of respiratory and critical care medicine.

[114]  P. Sterk,et al.  An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls. , 2012, Lung cancer.

[115]  Julian King,et al.  Blood and breath levels of selected volatile organic compounds in healthy volunteers. , 2013, The Analyst.

[116]  D. Murdoch,et al.  Detection of 2-pentylfuran in the breath of patients with Aspergillus fumigatus. , 2009, Medical mycology.

[117]  Bradford G. Stone,et al.  Effect of regulating cholesterol biosynthesis on breath isoprene excretion in men , 1993, Lipids.

[118]  P. Reilly,et al.  Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: cause, consequence or epiphenomenon? , 1992, Pharmacology & therapeutics.

[119]  Susan Budavari,et al.  The Merck index , 1998 .

[120]  Bogusław Buszewski,et al.  Human exhaled air analytics: biomarkers of diseases. , 2007, Biomedical chromatography : BMC.

[121]  D. B. Milligan,et al.  Real time analysis of breath volatiles using SIFT-MS in cigarette smoking , 2001, Redox report : communications in free radical research.

[122]  L. Freitag,et al.  Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study , 2009, Thorax.

[123]  Ki-Hyun Kim,et al.  Human body-odor components and their determination , 2011 .

[124]  B. Ross,et al.  Increased breath ethane levels in medicated patients with schizophrenia and bipolar disorder are unrelated to erythrocyte omega-3 fatty acid abundance , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[125]  Wilson Hk.  Breath analysis. Physiological basis and sampling techniques. , 1986 .

[126]  Ki-Hyun Kim,et al.  A review of breath analysis for diagnosis of human health , 2012 .

[127]  D. Blake,et al.  Ethane and n-pentane in exhaled breath are biomarkers of exposure not effect , 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[128]  P. Španěl,et al.  The challenge of breath analysis for clinical diagnosis and therapeutic monitoring. , 2007, The Analyst.

[129]  A. Jonckheere,et al.  Diabetes mellitus Induces a Thickening of the Pulmonary Basal Lamina , 1999, Respiration.

[130]  W. Miekisch,et al.  Diagnostic potential of breath analysis--focus on volatile organic compounds. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[131]  P. Španěl,et al.  Quantitative analysis of ammonia on the breath of patients in end-stage renal failure. , 1997, Kidney international.

[132]  A. Schneider,et al.  Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting. , 2012, Ginekologia polska.

[133]  D. Yates,et al.  Fractional exhaled nitric oxide in asthma: an update , 2010, Respirology.

[134]  N. Seiler,et al.  Ammonia and Alzheimer’s disease , 2002, Neurochemistry International.

[135]  M. Epton,et al.  Measurement of breath acetone concentrations by selected ion flow tube mass spectrometry in type 2 Diabetes , 2011, Journal of breath research.

[136]  G. Milne,et al.  Altered inflammatory, oxidative, and metabolic responses to exercise in pediatric obesity and type 1 diabetes , 2011, Pediatric diabetes.

[137]  M. Phillips,et al.  Breath tests in medicine. , 1992, Scientific American.

[138]  J. Mead,et al.  In vitro biosynthesis of isoprene from mevalonate utilizing a rat liver cytosolic fraction. , 1984, Biochemical and biophysical research communications.

[139]  J. Allard,et al.  Breath alkanes as a marker of oxidative stress in different clinical conditions. , 2000, Free radical biology & medicine.

[140]  Hong Yang,et al.  Intravenous glucose infusion decreases intracisternal thyrotropin-releasing hormone induced vagal stimulation of gastric acid secretion in anesthetized rats , 2003, Neuroscience Letters.

[141]  Wolfram Miekisch,et al.  From highly sophisticated analytical techniques to life-saving diagnostics: Technical developments in breath analysis , 2006 .

[142]  W. Miekisch,et al.  Breath biomarkers for lung cancer detection and assessment of smoking related effects--confounding variables, influence of normalization and statistical algorithms. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[143]  F. V. van Schooten,et al.  The versatile use of exhaled volatile organic compounds in human health and disease , 2012, Journal of breath research.

[144]  T. H. Risby.  CURRENT STATUS OF CLINICAL BREATH ANALYSIS , 2005 .

[145]  C. Olopade,et al.  Exhaled pentane levels in acute asthma. , 1997, Chest.

[146]  B. Buszewski,et al.  Identification of volatile lung cancer markers by gas chromatography–mass spectrometry: comparison with discrimination by canines , 2012, Analytical and Bioanalytical Chemistry.

[147]  Jeroen S. Dickschat,et al.  Bacterial volatiles: the smell of small organisms. , 2007, Natural product reports.

[148]  Kiyokatsu Jinno,et al.  Breath acetone analysis with miniaturized sample preparation device: in-needle preconcentration and subsequent determination by gas chromatography-mass spectroscopy. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[149]  T. Polák,et al.  A simple method for the trace determination of methanol, ethanol, acetone and pentane in human breath and in the ambient air by preconcentration on solid sorbents followed by gas chromatography. , 1997, Talanta.

[150]  M. Graw,et al.  Endogenous methanol: variability in concentration and rate of production. Evidence of a deep compartment? , 1996, Forensic science international.

[151]  Simone Meinardi,et al.  Noninvasive measurement of plasma glucose from exhaled breath in healthy and type 1 diabetic subjects. , 2011, American journal of physiology. Endocrinology and metabolism.

[152]  A. Tangerman,et al.  Cause and composition of foetor hepaticus , 1994, The Lancet.

[153]  M P van der Schee,et al.  External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[154]  H. Haick,et al.  Unique volatolomic signatures of TP53 and KRAS in lung cells , 2014, British Journal of Cancer.

[155]  E. Martinelli,et al.  Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. , 2003, Biosensors & bioelectronics.

[156]  Malina K. Storer,et al.  Analysis of biogenic volatile organic compounds in human health and disease , 2011 .

[157]  D. Blake,et al.  The clinical potential of exhaled breath analysis for diabetes mellitus. , 2012, Diabetes research and clinical practice.

[158]  Werner Lindinger,et al.  Proton transfer reaction mass spectrometry: on-line trace gas analysis at the ppb level , 1995 .

[159]  C. Chen,et al.  Applications of Hadamard transform-gas chromatography/mass spectrometry to the detection of acetone in healthy human and diabetes mellitus patient breath. , 2014, Talanta.

[160]  M. Phillips,et al.  Effect of oxygen on breath markers of oxidative stress , 2003, European Respiratory Journal.

[161]  C. Seger,et al.  Non-13CO2 targeted breath tests: a feasibility study , 2014, Journal of breath research.

[162]  G. Teschl,et al.  Breath isoprene: muscle dystrophy patients support the concept of a pool of isoprene in the periphery of the human body. , 2012, Biochemical and biophysical research communications.

[163]  J. W. COOK,et al.  “The Merck Index” , 1953, Nature.

[164]  Julian King,et al.  Physiological modeling of isoprene dynamics in exhaled breath. , 2010, Journal of theoretical biology.

[165]  A. B. Robinson,et al.  Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[166]  Y. Duan,et al.  Discovery of potential biomarkers in exhaled breath for diagnosis of type 2 diabetes mellitus based on GC-MS with metabolomics , 2014 .

[167]  P. Davis,et al.  Endogenous isopropanol: forensic and biochemical implications. , 1984, Journal of analytical toxicology.

[168]  P. Mazzone,et al.  Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer. , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[169]  M. Zeegers,et al.  Pulmonary function in diabetes: a metaanalysis. , 2010, Chest.

[170]  D. Blake,et al.  Exhaled breath and fecal volatile organic biomarkers of chronic kidney disease. , 2013, Biochimica et biophysica acta.

[171]  S. K. Vashist.  Non-invasive glucose monitoring technology in diabetes management: a review. , 2012, Analytica chimica acta.

[172]  Christopher Walton,et al.  Breath acetone concentration decreases with blood glucose concentration in type I diabetes mellitus patients during hypoglycaemic clamps , 2009, Journal of breath research.

[173]  David Smith,et al.  Time variation of ammonia, acetone, isoprene and ethanol in breath: a quantitative SIFT-MS study over 30 days. , 2003, Physiological measurement.

[174]  Mika Kivimäki,et al.  Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study , 2009, The Lancet.

[175]  T. Sharkey,et al.  Isoprene emission from plants: why and how. , 2007, Annals of botany.

[176]  T. Risby,et al.  Visceral lipid peroxidation occurs at reperfusion after supraceliac aortic cross-clamping. , 1994, Journal of vascular surgery.

[177]  Ralf Zimmermann,et al.  Automated needle trap heart-cut GC/MS and needle trap comprehensive two-dimensional GC/TOF-MS for breath gas analysis in the clinical environment. , 2010, Analytical chemistry.

[178]  Yong Liu,et al.  Breath analysis: technical developments and challenges in the monitoring of human exposure to volatile organic compounds. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[179]  A. Ziegler,et al.  Human breath gas analysis in the screening of gestational diabetes mellitus. , 2012, Diabetes Technology & Therapeutics.

[180]  Peter J Sterk,et al.  An electronic nose in the discrimination of patients with asthma and controls. , 2007, The Journal of allergy and clinical immunology.

[181]  Royston Goodacre,et al.  Taking your breath away: metabolomics breathes life in to personalized medicine. , 2014, Trends in biotechnology.

[182]  Jörg Ingo Baumbach,et al.  Detection of human metabolites using multi-capillary columns coupled to ion mobility spectrometers. , 2005, Journal of chromatography. A.

[183]  R. Dweik,et al.  Cardiovascular biomarkers in exhaled breath. , 2012, Progress in cardiovascular diseases.

[184]  Kohji Mitsubayashi,et al.  An acetone bio-sniffer (gas phase biosensor) enabling assessment of lipid metabolism from exhaled breath. , 2015, Biosensors & bioelectronics.

[185]  G. Sun,et al.  Quantitative breath analysis of volatile organic compounds of lung cancer patients. , 2010, Lung cancer.

[186]  H. K. Wilson.  Breath analysis. Physiological basis and sampling techniques. , 1986, Scandinavian journal of work, environment & health.

[187]  Claudio Ronco,et al.  Breath ethane in dialysis patients and control subjects. , 2003, Free radical biology & medicine.

[188]  D. Kohlmüller,et al.  Is n-pentane really an index of lipid peroxidation in humans and animals? A methodological reevaluation. , 1993, Analytical biochemistry.

[189]  P. T. Palmer,et al.  Proton transfer reaction ion trap mass spectrometer. , 2003, Rapid communications in mass spectrometry : RCM.

[190]  M. Phillips,et al.  Variation in volatile organic compounds in the breath of normal humans. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[191]  Peter J. Sterk,et al.  Volatile Metabolites of Pathogens: A Systematic Review , 2013, PLoS pathogens.

[192]  A. Alwan.  Global status report on noncommunicable diseases 2010. , 2011 .

[193]  P. Španěl,et al.  Ambient analysis of trace compounds in gaseous media by SIFT-MS. , 2011, The Analyst.

[194]  A. Tangerman,et al.  A new sensitive assay for measuring volatile sulphur compounds in human breath by Tenax trapping and gas chromatography and its application in liver cirrhosis. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[195]  M. Goldfarb.  That's life. , 1988, Journal of the Tennessee Medical Association.

[196]  P. Zimmerman,et al.  Exhaled breath analysis for lung cancer. , 2013, Journal of thoracic disease.

[197]  T R Fraser,et al.  Breath acetone and blood sugar measurements in diabetes. , 1969, Clinical science.

[198]  M. Statheropoulos,et al.  Trace detection of endogenous human volatile organic compounds for search, rescue and emergency applications , 2015 .

[199]  Jörg Ingo Baumbach,et al.  Ion mobility spectrometer for online monitoring of trace compounds , 2002 .

[200]  M. Edidin,et al.  THE ROLE OF MEMBRANE POTENTIAL IN DETERMINING RATES OF LATERAL DIFFUSION IN THE PLASMA MEMBRANE OF MAMMALIAN CELLS * , 1980, Annals of the New York Academy of Sciences.

[201]  Erica R Thaler,et al.  Diagnosis of Pneumonia With an Electronic Nose: Correlation of Vapor Signature With Chest Computed Tomography Scan Findings , 2004, The Laryngoscope.

[202]  Silvia Coradeschi,et al.  Direct Identification of Bacteria in Blood Culture Samples Using an Electronic Nose , 2010, IEEE Transactions on Biomedical Engineering.

[203]  M. Phillips,et al.  Ion-trap detection of volatile organic compounds in alveolar breath. , 1992, Clinical chemistry.

[204]  P. Barnes,et al.  Elevation of exhaled ethane concentration in asthma. , 2000, American journal of respiratory and critical care medicine.

[205]  Y. Dorokhov,et al.  Metabolic methanol: molecular pathways and physiological roles. , 2015, Physiological reviews.

[206]  C. Kneepkens,et al.  The potential of the hydrocarbon breath test as a measure of lipid peroxidation. , 1994, Free radical biology & medicine.

[207]  P. Sterk,et al.  Exhaled breath analysis by electronic nose in airways disease. Established issues and key questions , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[208]  Erica R Thaler,et al.  Electronic Nose Prediction of a Clinical Pneumonia Score: Biosensors and Microbes , 2005, Anesthesiology.

[209]  J. P. Conkle,et al.  Trace composition of human respiratory gas. , 1975, Archives of environmental health.

[210]  K. Naitoh,et al.  Is endogenous isoprene the only coeluting compound in the measurement of breath pentane? , 2000, Clinica chimica acta; international journal of clinical chemistry.

[211]  Gert Mayer,et al.  Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease , 2014, BMC Nephrology.

[212]  A. Antoshechkin.  On intracellular formation of ethanol and its possible role in energy metabolism. , 2001, Alcohol and alcoholism.

[213]  M. Shepherd,et al.  A Study on Breath Acetone in Diabetic Patients Using a Cavity Ringdown Breath Analyzer: Exploring Correlations of Breath Acetone With Blood Glucose and Glycohemoglobin A1C , 2010, IEEE Sensors Journal.

[214]  Anton Amann,et al.  Breath analysis by nanostructured metal oxides as chemo-resistive gas sensors , 2015 .

[215]  A. Dzien,et al.  Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants , 2012, Journal of breath research.

[216]  David Smith,et al.  A longitudinal study of ammonia, acetone and propanol in the exhaled breath of 30 subjects using selected ion flow tube mass spectrometry, SIFT-MS , 2006, Physiological measurement.

[217]  P. Sobotka,et al.  High breath pentane concentrations during acute myocardial infarction , 1991, The Lancet.

[218]  P. K. Gupta.  Absorption, distribution, and excretion of toxicants , 2016 .

[219]  Richard Barnett.  Diabetes , 1904, The Lancet.

[220]  B. Knick.  [Definition and classification of diabetes mellitus]. , 1966, Schweizerische medizinische Wochenschrift.

[221]  M. Kalapos,et al.  On the mammalian acetone metabolism: from chemistry to clinical implications. , 2003, Biochimica et biophysica acta.

[222]  B. Costello,et al.  The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva , 2014, Journal of breath research.

[223]  G. Rooth,et al.  Acetone in alveolar air, and the control of diabetes. , 1966, Lancet.

[224]  M. Quirynen,et al.  GC-MS analysis of breath odor compounds in liver patients. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[225]  Olaf Tietje,et al.  Volatile biomarkers of pulmonary tuberculosis in the breath. , 2007, Tuberculosis.

[226]  Onofrio Resta,et al.  An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. , 2009, Lung cancer.

[227]  Breath pentane and plasma lipid peroxides in ischemic heart disease. , 1995, Free radical biology & medicine.

[228]  S. Chambers,et al.  Investigation into the production of 2-Pentylfuran by Aspergillus fumigatus and other respiratory pathogens in vitro and human breath samples. , 2008, Medical mycology.

[229]  W. Miekisch,et al.  Breath gas aldehydes as biomarkers of lung cancer , 2009, International journal of cancer.

[230]  W. Miekisch,et al.  Breath Markers and Soluble Lipid Peroxidation Markers in Critically Ill Patients , 2002, Clinical chemistry and laboratory medicine.

[231]  L. Laffel.  Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes , 1999, Diabetes/metabolism research and reviews.

[232]  K. Torén,et al.  Determination of ethane, pentane and isoprene in exhaled air – effects of breath‐holding, flow rate and purified air , 2007, Acta physiologica.